Geoff Meacham

Stock Analyst at Citigroup

(3.74)
# 660
Out of 4,781 analysts
237
Total ratings
55.1%
Success rate
4.63%
Average return

Stocks Rated by Geoff Meacham

Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $31.48
Upside: +27.06%
Kymera Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $52
Current: $30.39
Upside: +71.11%
Kiniksa Pharmaceuticals International,
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $22.76
Upside: +75.75%
BioNTech SE
Mar 13, 2025
Initiates: Buy
Price Target: $145
Current: $95.90
Upside: +51.20%
Avidity Biosciences
Mar 13, 2025
Initiates: Buy
Price Target: $70
Current: $32.05
Upside: +118.41%
Apogee Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $40.14
Upside: +136.67%
89bio
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $8.02
Upside: +211.72%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $99$103
Current: $71.48
Upside: +44.10%
Biogen
Feb 13, 2025
Maintains: Neutral
Price Target: $160$145
Current: $142.43
Upside: +1.80%
AbbVie
Feb 3, 2025
Maintains: Buy
Price Target: $205$215
Current: $201.30
Upside: +6.81%
Maintains: Neutral
Price Target: $795$750
Current: $640.14
Upside: +17.16%
Maintains: Neutral
Price Target: $310$295
Current: $305.71
Upside: -3.50%
Maintains: Buy
Price Target: $98$85
Current: $39.18
Upside: +116.95%
Downgrades: Underperform
Price Target: $112$4
Current: $2.18
Upside: +83.49%
Maintains: Buy
Price Target: $22$7
Current: $1.09
Upside: +542.20%
Maintains: Buy
Price Target: $42$45
Current: $36.10
Upside: +24.65%
Initiates: Buy
Price Target: $125
Current: $109.27
Upside: +14.40%
Initiates: Buy
Price Target: $575
Current: $500.28
Upside: +14.94%
Maintains: Buy
Price Target: $1,150$1,100
Current: $826.76
Upside: +33.05%
Downgrades: Underperform
Price Target: $6$1
Current: $0.56
Upside: +79.28%
Upgrades: Buy
Price Target: $22$31
Current: $10.24
Upside: +202.73%
Maintains: Buy
Price Target: $12$10
Current: $0.40
Upside: +2,400.00%
Maintains: Buy
Price Target: $150$145
Current: $88.15
Upside: +64.50%
Maintains: Neutral
Price Target: $180$170
Current: $161.72
Upside: +5.12%
Maintains: Buy
Price Target: $40$38
Current: $31.56
Upside: +20.41%
Maintains: Buy
Price Target: $24$48
Current: $30.12
Upside: +59.36%
Downgrades: Neutral
Price Target: $68$60
Current: $59.21
Upside: +1.33%
Downgrades: Neutral
Price Target: $8
Current: $1.23
Upside: +550.41%
Downgrades: Neutral
Price Target: $23$14
Current: $6.59
Upside: +112.44%
Maintains: Underperform
Price Target: $10$8
Current: $2.85
Upside: +180.70%
Maintains: Buy
Price Target: $19$17
Current: $1.43
Upside: +1,088.81%
Reinstates: Buy
Price Target: $14
Current: $1.16
Upside: +1,106.90%
Maintains: Neutral
Price Target: $50$45
Current: $25.21
Upside: +78.50%
Initiates: Buy
Price Target: $50
Current: $3.81
Upside: +1,212.34%
Downgrades: Underperform
Price Target: $24
Current: $1.75
Upside: +1,271.43%
Downgrades: Neutral
Price Target: $12$4
Current: $8.52
Upside: -53.05%
Initiates: Buy
Price Target: $28
Current: $1.48
Upside: +1,791.89%
Initiates: Buy
Price Target: $34
Current: $0.56
Upside: +6,015.11%
Upgrades: Buy
Price Target: $56
Current: $4.84
Upside: +1,057.02%
Downgrades: Neutral
Price Target: $35
Current: $1.63
Upside: +2,047.24%
Initiates: Buy
Price Target: $525
Current: $3.94
Upside: +13,224.87%
Initiates: Buy
Price Target: $42
Current: $1.16
Upside: +3,520.69%
Reinstates: Buy
Price Target: $20
Current: $7.23
Upside: +176.63%
Reinstates: Buy
Price Target: $20
Current: $0.85
Upside: +2,266.86%
Reinstates: Underperform
Price Target: $9
Current: $3.13
Upside: +187.54%
Reinstates: Buy
Price Target: $60
Current: $8.20
Upside: +631.71%
Initiates: Underperform
Price Target: $7
Current: $3.48
Upside: +101.15%
Maintains: Equal-Weight
Price Target: $15$23
Current: $12.35
Upside: +86.23%
Downgrades: Equal-Weight
Price Target: $90$82
Current: $61.26
Upside: +33.86%
Maintains: Underweight
Price Target: $100$95
Current: $310.82
Upside: -69.44%
Downgrades: Equal-Weight
Price Target: $300$80
Current: $4.05
Upside: +1,875.31%
Maintains: Equal-Weight
Price Target: $43$40
Current: $55.31
Upside: -27.68%
Maintains: Overweight
Price Target: $100$135
Current: $114.45
Upside: +17.96%
Downgrades: Underweight
Price Target: n/a
Current: $13.37
Upside: -
Maintains: Equal-Weight
Price Target: $16$20
Current: $1.46
Upside: +1,269.86%
Downgrades: Equal-Weight
Price Target: n/a
Current: $28.86
Upside: -
Maintains: Overweight
Price Target: $127$158
Current: $269.21
Upside: -41.31%